Eton Pharmaceuticals (ETON) Net Cash Flow Growth (1y) (2019 - 2025)
Eton Pharmaceuticals (ETON) Net Cash Flow Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | -1,020.00% |
| 10 | Eton Pharmaceuticals | 1.15 Bn | 1.13 Bn | 13.10 Mn | -109.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -109.93% |
| Sep 30, 2025 | 357.42% |
| Jun 30, 2025 | 666.03% |
| Mar 31, 2025 | 152.48% |
| Dec 31, 2024 | -680.79% |
| Sep 30, 2024 | 409.33% |
| Jun 30, 2024 | -84.85% |
| Mar 31, 2024 | -196.37% |
| Dec 31, 2023 | -123.30% |
| Sep 30, 2023 | 113.74% |
| Jun 30, 2023 | 277.44% |
| Mar 31, 2023 | -294.05% |
| Dec 31, 2022 | 135.25% |
| Sep 30, 2022 | -18.59% |
| Jun 30, 2022 | 22,812.50% |
| Mar 31, 2022 | -78.44% |
| Dec 31, 2021 | -159.46% |
| Sep 30, 2021 | -5.28% |
| Jun 30, 2021 | 99.61% |
| Mar 31, 2021 | 1,319.33% |